The DOI matches its Crossref record; 237 of the 237 references it cites were found in a registry or an index.
Targeting mitochondria for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Self-citationAn inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Self-citationExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
Self-citationATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion
Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.025 · Cited by 1,673
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., Inohara, H., Kubo, T., & Tsujimoto, Y. (2005) · Nature · doi:10.1038/nature03317 · Cited by 1,635
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Translocation of Proteins into Mitochondria
Neupert, W., & Herrmann, J. M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.163409 · Cited by 1,481
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., & Newmeyer, D. D. (2002) · Cell · doi:10.1016/s0092-8674(02)01036-x · Cited by 1,478
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
Ito, K., Hirao, A., Arai, F., Takubo, K., Matsuoka, S., Miyamoto, K., Ohmura, M., Naka, K., Hosokawa, K., Ikeda, Y., et al. (2006) · Nature Medicine · doi:10.1038/nm1388 · Cited by 1,362
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Wang, J.-L., Liu, D., Zhang, Z.-J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201
Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells
Ito, K., Hirao, A., Arai, F., Matsuoka, S., Takubo, K., Hamaguchi, I., Nomiyama, K., Hosokawa, K., Sakurada, K., Nakagata, N., et al. (2004) · Nature · doi:10.1038/nature02989 · Cited by 1,175
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168
Self-citationSelective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., & Wallace, D. C. (2004) · Nature · doi:10.1038/nature02229 · Cited by 1,086
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Trachootham, D., Zhou, Y., Zhang, H., Demizu, Y., Chen, Z., Pelicano, H., Chiao, P. J., Achanta, G., Arlinghaus, R. B., Liu, J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.009 · Cited by 1,080
Cell death by necrosis: towards a molecular definition
Golstein, P., & Kroemer, G. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.001 · Cited by 1,044
Self-citationKonopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death
Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J., & Molkentin, J. D. (2007) · Nature Cell Biology · doi:10.1038/ncb1575 · Cited by 971
The role of oxygen availability in embryonic development and stem cell function
Simon, M. C., & Keith, B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2354 · Cited by 967
Foxo3a is essential for maintenance of the hematopoietic stem cell pool
Miyamoto, K., Kazuhito, N., & Atsushi, H. (2009) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 892
Mootha, V. K., Bunkenborg, J., Olsen, J. V., Hjerrild, M., Wisniewski, J. R., Stahl, E., Bolouri, M. S., Ray, H. N., Sihag, S., Kamal, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00926-7 · Cited by 889
Superoxide dismutase as a target for the selective killing of cancer cells
Huang, P., Feng, L., Oldham, E. A., Keating, M. J., & Plunkett, W. (2000) · Nature · doi:10.1038/35030140 · Cited by 842
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
Life in the balance: how BH3-only proteins induce apoptosis
Willis, S. N., & Adams, J. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.10.001 · Cited by 743
Cipolat, S., Rudka, T., Hartmann, D., Costa, V., Serneels, L., Craessaerts, K., Metzger, K., Frezza, C., Annaert, W., D'Adamio, L., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.021 · Cited by 741
Bcl-2 Gene Family and the Regulation of Programmed Cell Death
Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., Linette, G. P., & Korsmeyer, S. J. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.043 · Cited by 723
Semenza, G. L. (2007) · Science · doi:10.1126/science.1147949 · Cited by 703
BAX activation is initiated at a novel interaction site
Gavathiotis, E., Suzuki, M., Davis, M. L., Pitter, K., Bird, G. H., Katz, S. G., Tu, H.-C., Kim, H., Cheng, E. H.-Y., Tjandra, N., et al. (2008) · Nature · doi:10.1038/nature07396 · Cited by 700
The Increasing Complexity of the Cancer Stem Cell Paradigm
Rosen, J. M., & Jordan, C. T. (2009) · Science · doi:10.1126/science.1171837 · Cited by 698
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Nguyen, M., Marcellus, R. C., Roulston, A., Watson, M., Serfass, L., Murthy Madiraju, S. R., Goulet, D., Viallet, J., Bélec, L., Billot, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709443104 · Cited by 659
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · cited 1×
“Betulinic acid (3b, hydroxy-lup-20(29)-en-28-oic acid) is a natural pentacyclic triterpenoid of the lupane class that is contained in various species throughout the plant kingdo”
BackgroundMitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., Chandel, N. S., Thompson, C. B., Robey, R. B., & Hay, N. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.014 · Cited by 633
Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario
Chipuk, J. E., Bouchier-Hayes, L., & Green, D. R. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401963 · Cited by 631
BCL-2 family antagonists for cancer therapy
Lessene, G., Czabotar, P. E., & Colman, P. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2658 · Cited by 621
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
Fulda, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24064 · Cited by 615
Self-citationMorrison, D. K. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.003 · Cited by 605
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586
Self-citationLovell, J. F., Billen, L. P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., & Andrews, D. W. (2008) · Cell · doi:10.1016/j.cell.2008.11.010 · Cited by 563
Necroptosis: A Specialized Pathway of Programmed Necrosis
Galluzzi, L., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2008.12.004 · Cited by 561
Self-citationCichewicz, R. H., & Kouzi, S. A. (2004) · Medicinal Research Reviews · doi:10.1002/med.10053 · Cited by 531
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Zuco, V., Supino, R., Righetti, S. C., Cleris, L., Marchesi, E., Gambacorti-Passerini, C., & Formelli, F. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00718-2 · Cited by 530
Petronilli, V., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S., & Bernardi, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89437-1 · Cited by 529
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526
Mitochondria-Penetrating Peptides
Horton, K. L., Stewart, K. M., Fonseca, S. B., Guo, Q., & Kelley, S. O. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.015 · Cited by 465
Terpenes: substances useful in human healthcare
Paduch, R., Kandefer-Szerszeń, M., Trytek, M., & Fiedurek, J. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0039-1 · Cited by 448
Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network
Kang, B. H., Plescia, J., Dohi, T., Rosa, J., Doxsey, S. J., & Altieri, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.028 · Cited by 443
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Smith, J., Ladi, E., Mayer-Pröschel, M., & Noble, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170209797 · Cited by 399
Pastorino, J. G., Hoek, J. B., & Shulga, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1925 · Cited by 398
Chen, S., Dai, Y., Harada, H., Dent, P., & Grant, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3964 · Cited by 385
Mechanism of inhibition of bovine F 1 -ATPase by resveratrol and related polyphenols
Gledhill, J. R., Montgomery, M. G., Leslie, A. G. W., & Walker, J. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706290104 · Cited by 379
Kitada, S., Leone, M., Sareth, S., Zhai, D., Reed, J. C., & Pellecchia, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030190z · Cited by 379
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
Self-citationSelective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
Vogler, M., Dinsdale, D., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.137 · Cited by 357
Bey, E. A., Bentle, M. S., Reinicke, K. E., Dong, Y., Yang, C.-R., Girard, L., Minna, J. D., Bornmann, W. G., Gao, J., & Boothman, D. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702176104 · Cited by 354
Elesclomol induces cancer cell apoptosis through oxidative stress
Kirshner, J. R., He, S., Balasubramanyam, V., Kepros, J., Yang, C.-Y., Zhang, M., Du, Z., Barsoum, J., & Bertin, J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0298 · Cited by 353
BCL-2 gene family and the regulation of programmed cell death.
Korsmeyer, S. J. (1999) · PubMed · Cited by 352
Cragg, M. S., Kuroda, J., Puthalakath, H., Huang, D. C. S., & Strasser, A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040316 · Cited by 343
Fulda, S., Friesen, C., Łoś, M., Scaffidi, C., Mier, W., Benedict, M., Núñez, G., Krammer, P. H., Peter, M. E., & Debatin, K. (1997) · PubMed · Cited by 342
Self-citationRational design of shepherdin, a novel anticancer agent
Plescia, J., Salz, W., Xia, F., Pennati, M., Zaffaroni, N., Daidone, M. G., Meli, M., Dohi, T., Fortugno, P., Nefedova, Y., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.035 · Cited by 341
Miyamoto, S., Murphy, A. N., & Brown, J. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402285 · Cited by 339
Mitochondria as therapeutic targets for cancer chemotherapy
Galluzzi, L., Larochette, N., Zamzami, N., & Kroemer, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209598 · Cited by 337
Self-citationKuroda, J., Puthalakath, H., Cragg, M. S., Kelly, P. N., Bouillet, P., Huang, D. C. S., Kimura, S., Ottmann, O. G., Druker, B. J., Villunger, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606176103 · Cited by 336
Lehenkari, P. P., Kellinsalmi, M., Näpänkangas, J. P., Ylitalo, K. V., Mönkkönen, J., Rogers, M. J., Azhayev, A., Väänänen, H. K., & Hassinen, I. E. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12222-5 · Cited by 333
Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications
Yousif, L. F., Stewart, K. M., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900185 · Cited by 330
Yamada, Y., Akita, H., Kamiya, H., Kogure, K., Yamamoto, T., Shinohara, Y., Yamashita, K., Kobayashi, H., Kikuchi, H., & Harashima, H. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.002 · Cited by 321
Gong, Y., Somwar, R., Politi, K., Balak, M., Chmielecki, J., Jiang, X., & Pao, W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040294 · Cited by 321
Caldas-Lopes, E., Cerchietti, L., Ahn, J. H., Clement, C. C., Robles, A. I., Rodina, A., Moulick, K., Taldone, T., Gozman, A., Guo, Y., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903392106 · Cited by 315
Beckers, A., Organe, S., Timmermans, L., Scheys, K., Peeters, A., Brusselmans, K., Verhoeven, G., & Swinnen, J. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0389 · Cited by 314
Antitumor effects of bisphosphonates
Green, J. R. (2003) · Cancer · doi:10.1002/cncr.11128 · Cited by 311
O'Brien, S., Moore, J. O., Boyd, T. E., Larratt, L. M., Skotnicki, A., Koziner, B., Chanan-Khan, A. A., Seymour, J. F., Bociek, R. G., Pavletic, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1191 · Cited by 303
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Self-citationMitochondrial dysfunction in cancer
Modica-Napolitano, J. S., & Singh, K. K. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.027 · Cited by 299
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
Dong, L.-F., Low, P., Dyason, J. C., Wang, X.-F., Prochazka, L., Witting, P. K., Freeman, R., Swettenham, E., Valis, K., Liu, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.69 · Cited by 297
Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., Sollott, S. J., Forte, M., Bernardi, P., & Rasola, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001852 · Cited by 290
NEUZIL, J., WEBER, T., SCHRÖDER, A., LU, M., OSTERMANN, G., GELLERT, N., MAYNE, G. C., OLEJNICKA, B., NÈGRE‐SALVAYRE, A., STÍCHA, M., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0251com · Cited by 287
Costantini, P., Belzacq, A.-S., Vieira, H. L., Larochette, N., de Pablo, M. A., Zamzami, N., Susin, S. A., Brenner, C., & Kroemer, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203299 · Cited by 284
Self-citationVitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
Constantinou, C., Papas, A., & Constantinou, A. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23689 · Cited by 281
Bauer, M. K. A., Schubert, A., Rocks, O., & Grimm, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1493 · Cited by 278
O'Brien, S. M., Claxton, D. F., Crump, M., Faderl, S., Kipps, T., Keating, M. J., Viallet, J., & Cheson, B. D. (2009) · Blood · doi:10.1182/blood-2008-02-137943 · Cited by 274
Display technologies: Application for the discovery of drug and gene delivery agents☆
SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.018 · Cited by 266
Konopleva, M., Watt, J., Contractor, R., Tsao, T., Harris, D., Estrov, Z., Bornmann, W., Kantarjian, H., Viallet, J., Samudio, I., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1919 · Cited by 265
Pathania, D., Millard, M., & Neamati, N. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.010 · Cited by 263
Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women
Canter, J. A., Kallianpur, A. R., Parl, F. F., & Millikan, R. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1428 · Cited by 258
Juarez, J. C., Manuia, M., Burnett, M. E., Betancourt, O., Boivin, B., Shaw, D. E., Tonks, N. K., Mazar, A. P., & Doñate, F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709451105 · Cited by 257
No death without life: vital functions of apoptotic effectors
Galluzzi, L., Joza, N., Tasdemir, E., Maiuri, M. C., Hengartner, M., Abrams, J. M., Tavernarakis, N., Penninger, J., Madeo, F., & Kroemer, G. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.28 · Cited by 257
Self-citationMolecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
Fulda, S., Susín, S. A., Kroemer, G., & Debatin, K. (1998) · PubMed · Cited by 243
Self-citationKang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
Simons, A. L., Ahmad, I. M., Mattson, D. M., Dornfeld, K. J., & Spitz, D. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3717 · Cited by 238
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 234
Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
Chen, Z., Zhang, H., Lu, W., & Huang, P. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.03.003 · Cited by 230
Methods for the assessment of mitochondrial membrane permeabilization in apoptosis
Galluzzi, L., Zamzami, N., de La Motte Rouge, T., Lemaire, C., Brenner, C., & Kroemer, G. (2007) · Apoptosis · doi:10.1007/s10495-007-0720-1 · Cited by 224
Self-citationTagscherer, K. E., Fassl, A., Campos, B., Farhadi, M., Kraemer, A., Böck, B. C., Macher-Goeppinger, S., Radlwimmer, B., Wiestler, O. D., Herold-Mende, C., et al. (2008) · Oncogene · doi:10.1038/onc.2008.259 · Cited by 220
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Trudel, S., Li, Z. H., Rauw, J., Tiedemann, R. E., Wen, X. Y., & Stewart, A. K. (2007) · Blood · doi:10.1182/blood-2006-10-047951 · Cited by 218
Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer
Hann, C. L., Daniel, V. C., Sugar, E. A., Dobromilskaya, I., Murphy, S. C., Cope, L., Lin, X., Hierman, J. S., Wilburn, D. L., Watkins, D. N., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5031 · Cited by 214
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., Bronner, V, Notcovich, A., Shoshan-Barmatz, V, & Flescher, E. (2008) · Oncogene · doi:10.1038/onc.2008.108 · Cited by 208
O'Day, S., Gonzalez, R., Lawson, D., Weber, R., Hutchins, L., Anderson, C., Haddad, J., Kong, S., Williams, A., & Jacobson, E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1579 · Cited by 208
Cragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., & Scott, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35437 · Cited by 207
Chen, C., Ko, Y., Delannoy, M., Ludtke, S. J., Chiu, W., & Pedersen, P. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401353200 · Cited by 206
Different forms of cell death induced by putative BCL2 inhibitors
Vogler, M., Weber, K., Dinsdale, D., Schmitz, I., Schulze-Osthoff, K., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.48 · Cited by 203
Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis
Bellancé, N. (2009) · Frontiers in bioscience · doi:10.2741/3509 · Cited by 201
DNA-protein conjugates can enter mitochondria via the protein import pathway
Vestweber, D., & Schatz, G. (1989) · Nature · doi:10.1038/338170a0 · Cited by 199
Alexandre, J., Nicco, C., Chéreau, C., Laurent, A., Weill, B., Goldwasser, F., & Batteux, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj049 · Cited by 199
Wang, H. Q., Altomare, D. A., Skele, K. L., Poulikakos, P. I., Kuhajda, F. P., Di Cristofano, A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208463 · Cited by 198
Belzacq, A.-S., El Hamel, C., Vieira, H. L. A., Cohen, I., Haouzi, D., Métivier, D., Marchetti, P., Brenner, C., & Kroemer, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204953 · Cited by 194
Self-citationDQAsomes: A Novel Potential Drug and Gene Delivery System Made from Dequalinium™
Weissig, V., Lasch, J., Erdos, G., Meyer, H. W., Rowe, T. C., & Hughes, J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011991307631 · Cited by 193
Schimmer, A. D., O'Brien, S., Kantarjian, H., Brandwein, J., Cheson, B. D., Minden, M. D., Yee, K., Ravandi, F., Giles, F., Schuh, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0999 · Cited by 192
Pérez-Galán, P., Roué, G., Villamor, N., Campo, E., & Colomer, D. (2007) · Blood · doi:10.1182/blood-2006-07-034173 · Cited by 190
Tan, Y., Yu, R., & Pezzuto, J. M. (2003) · PubMed · Cited by 189
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease
Srivastava, S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3093 · Cited by 187
Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., & Kakizuka, A. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401389 · Cited by 183
Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A., & Greil, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0675fje · Cited by 183
Self-citationLiu, G., Kelly, W. K., Wilding, G., Leopold, L., Brill, K., & Somer, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2985 · Cited by 181
Sweeney, C., Liu, G., Yiannoutsos, C., Kolesar, J., Horvath, D., Staab, M. J., Fife, K., Armstrong, V., Treston, A., Sidor, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0440 · Cited by 172
Carvalho, M. A., Zecchin, K. G., Seguin, F., Bastos, D. C., Agostini, M., Rangel, A. L. C. A., Veiga, S. S., Raposo, H. F., Oliveira, H. C. F., Loda, M., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23835 · Cited by 171
Mitochondria‐Penetrating Peptides: Sequence Effects and Model Cargo Transport
Yousif, L. F., Stewart, K. M., Horton, K. L., & Kelley, S. O. (2009) · ChemBioChem · doi:10.1002/cbic.200900017 · Cited by 167
Bcl-2 and Bax modulate adenine nucleotide translocase activity.
Belzacq, A.-S., Vieira, H. L. A., Verrier, F., Vandecasteele, G., Cohen, I., Prévost, M., Larquet, É., Pariselli, F., Petit, P. X., Kahn, A., et al. (2003) · PubMed · Cited by 167
Self-citationRudin, C. M., Salgia, R., Wang, X., Hodgson, L. D., Masters, G. A., Green, M., & Vokes, E. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3461 · Cited by 166
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., Patchell, R. A., Glantz, M. J., Recht, L., Langer, C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.068 · Cited by 164
Decaudin, D., Castedo, M., Némati, F., Beurdeley‐Thomas, A., Pinieux, G. D. B. D., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G., et al. (2002) · PubMed · Cited by 162
Self-citationMitochondria as targets for cancer chemotherapy
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.007 · Cited by 162
Motexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
Kang, M. H., Kang, Y. H., Szymanska, B., Wilczynska-Kalak, U., Sheard, M. A., Harned, T. M., Lock, R. B., & Reynolds, C. P. (2007) · Blood · doi:10.1182/blood-2007-03-080325 · Cited by 159
Bellot, G., Cartron, P., Er, E., Oliver, L., Juin, P. P., Armstrong, L. C., BORNSTEIN, P. K., Mihara, K., Manon, S., & Vallette, F. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402055 · Cited by 158
Don, A. S., Kisker, O., Dilda, P. J., Donoghue, N., Zhao, X., Decollogne, S., Creighton, B., Flynn, E. A., Folkman, J., & Hogg, P. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00109-0 · Cited by 156
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
Rodina, A., Vilenchik, M., Moulick, K., Aguirre, J., Kim, J., Chiang, A., Litz, J., Clement, C. C., Kang, Y., She, Y., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.10 · Cited by 156
Shoemaker, A. R., Oleksijew, A., Bauch, J. L., Belli, B., Borre, T., Bruncko, M., Deckwirth, T., Frost, D. J., Jarvis, K., Joseph, M. K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0367 · Cited by 151
Kütük, Ö., & Letai, A. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1418 · Cited by 146
Wick, W., Grimmel, C., Wagenknecht, B., DICHGANS, J., & Weller, M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38274-6 · Cited by 145
Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors
Fulda, S., & Debatin, K. (2000) · Medical and Pediatric Oncology · Cited by 142
Self-citationIn vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
Mason, K. D., Vandenberg, C. J., Scott, C. L., Wei, A. H., Cory, S., Huang, D. C. S., & Roberts, A. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809957105 · Cited by 140
Contributions to Bax insertion and oligomerization of lipids of the mitochondrial outer membrane
Lucken‐Ardjomande, S., Montessuit, S., & Martinou, J. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.9 · Cited by 139
Dong, L., Freeman, R., Liu, J., Zobalová, R., Marín‐Hernández, Á., Stantic, M., Rohlena, J., Vališ, K., Rodríguez‐Enríquez, S., Butcher, B., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2439 · Cited by 138
Manero, F., Gautier, F., Gallenne, T., Cauquil, N., Gree, D. M., Cartron, P., Geneste, O., Gree, R. L., Vallette, F. M., & Juin, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2097 · Cited by 135
VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase
Wright, G. L., Maroulakou, I. G., Eldridge, J. D., Liby, T. L., Sridharan, V., Tsichlis, P. N., & Muise‐Helmericks, R. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-106468 · Cited by 134
Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
André, N., Carré, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C. M., & Braguer, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03691-8 · Cited by 133
Tsatmali, M., Walcott, E. C., & Crossin, K. L. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.087 · Cited by 133
Meng, R. D., & El‐Deiry, W. S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5073 · Cited by 130
Curry, E. A., Murry, D. J., Yoder, C., Fife, K., Armstrong, V., Nakshatri, H., O’Connell, M., & Sweeney, C. J. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000026256.38560.be · Cited by 129
Xiao, D., Lew, K. L., Zeng, Y., Xiao, H., Marynowski, S. W., Dhir, R., & Singh, S. V. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl087 · Cited by 126
Marchetti, P., Zamzami, N., Joseph, B., Schraen‐Maschke, S., Méreau-Richard, C., Costantini, P., Métivier, D., Susín, S. A., Kroemer, G., & Formstecher, P. (1999) · PubMed · Cited by 125
Self-citationSternberg, C. N., Dumez, H., Poppel, H. V., Skoneczna, I., Sella, A., Daugaard, G., Gil, T., Graham, J., Carpentier, P., Calabrò, F., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn784 · Cited by 125
Non‐peptidic small molecule inhibitors against Bcl‐2 for cancer therapy
Azmi, A. S., & Mohammad, R. M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21567 · Cited by 123
Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program
Lock, R. B., Carol, H., Houghton, P. J., Morton, C. L., Kolb, E. A., Gorlick, R. G., Reynolds, C. P., Maris, J. M., Keir, S. T., Wu, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21433 · Cited by 123
Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
Tevaarwerk, A. J., Holen, K. D., Alberti, D. B., Sidor, C. F., Arnott, J., Quon, C. Y., Wilding, G., & Liu, G. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1599 · Cited by 123
Huang, S., & Sinicrope, F. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2508 · Cited by 122
Paoluzzi, L., Gönen, M., Bhagat, G., Furman, R. R., Gardner, J. R., Scotto, L., Gueorguiev, V. D., Heaney, M. L., Manova, K., & O’Connor, O. A. (2008) · Blood · doi:10.1182/blood-2007-12-130781 · Cited by 121
Kohl, T. M., Hellinger, C., Ahmed, F., Buske, C., Hiddemann, W., Bohlander, S. K., & Spiekermann, K. (2007) · Leukemia · doi:10.1038/sj.leu.2404776 · Cited by 119
Yamada, Y., Akita, H., Kogure, K., Kamiya, H., & Harashima, H. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.12.003 · Cited by 118
Phase II Study of Lonidamine and Diazepam in the Treatment of Recurrent Glioblastoma Multiforme
Oudard, S. M., Carpentier, A., Banu, E., Fauchon, F., Célérier, D., Poupon, M. F., Dutrillaux, B., Andrieu, J. M., & Delattre, J. ‐. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1023756707900 · Cited by 117
Berkenblit, A., Eder, J. P., Ryan, D. P., Seiden, M. V., Tatsuta, N., Sherman, M. L., Dahl, T. A., Dezube, B. J., & Supko, J. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0964 · Cited by 117
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
Kim, W. K., Yoon, J., Jeong, J. M., Cheon, G. J., Lee, T. S., Yang, J. I., Park, S.-C., & Lee, H.-S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0115 · Cited by 115
Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells
Zamora, M., Granell, M., Mampel, T., & Viñas, O. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00293-5 · Cited by 112
Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells
Thurnher, D., Turhani, D., Pelzmann, M., Wannemacher, B., Knerer, B., Formanek, M., Wacheck, V., & Selzer, E. (2003) · Head & Neck · doi:10.1002/hed.10231 · Cited by 111
Chemosensitization by Knockdown of Adenine Nucleotide Translocase-2
Bras, M. L., Borgne‐Sanchez, A., Touat-Hamici, Z., Dein, O. S. E., Deniaud, A., Maillier, E., Lecellier, G. J., Rebouillat, D., Lemaire, C., Kroemer, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4407 · Cited by 109
Self-citationPhase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors
Lowndes, S. A., Adams, A., Timms, A., Fisher, N., Smythe, J., Watt, S. M., Joel, S., Doñate, F., Hayward, C., Reich, S. D., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0315 · Cited by 107
Kitada, S., Kress, C. L., Krajewska, M., et al. (2008) · Blood · doi:10.1182/blood-2007-09-113647 · Cited by 106
Disruption of the hexokinase–VDAC complex for tumor therapy
Galluzzi, L., Kepp, O., Tajeddine, N., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.114 · Cited by 106
Self-citationDevelopment of mitochondria-targeted derivatives of resveratrol
Biasutto, L., Mattarei, A., Marotta, E., Bradaschia, A., Nicola Sassi, A., Garbisa, S., Zoratti, M., & Paradisi, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.100 · Cited by 106
Dong, L., Swettenham, E., Eliasson, J., Wang, X., Gold, M., Medunic, Y., Stantic, M., Low, P., Procházka, L., Witting, P. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3034 · Cited by 106
Galiègue, S., Casellas, P., Kramar, A., Tinel, N., & Simony-Lafontaine, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0988 · Cited by 104
Mason, K. D., Khaw, S. L., Rayeroux, K. C., Chew, E., Lee, E. F., Fairlie, W. D., Grigg, A., Seymour, J. F., Szer, J., Huang, D. C. S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.151 · Cited by 103
Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery
Zhivotovsky, B., Galluzzi, L., Kepp, O., & Kroemer, G. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.118 · Cited by 102
Self-citationMatei, D. E., Schilder, J. M., Sutton, G. P., Perkins, S. M., Breen, T., Quon, C. Y., & Sidor, C. F. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.042 · Cited by 101
González‐Polo, R. A., Carvalho, G., Braun, T., Decaudin, D., Fabre, C., Larochette, N., Perfettini, J., Djavaheri‐Mergny, M., Youlyouz‐Marfak, I., Codogno, P., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208907 · Cited by 101
Self-citationTang, X., Zhang, Q., Shi, S., Yen, Y., Li, X., Zhang, Y., Zhou, K., & Le, A. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24710 · Cited by 95
Ross, M. F., Filipovska, A., Smith, R. A. J., Gait, M. J., & Murphy, M. P. (2004) · Biochemical Journal · doi:10.1042/bj20041095 · Cited by 94
Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 Inhibitors
Gyurkocza, B., Plescia, J., Raskett, C. M., Garlick, D. S., Lowry, P. A., Carter, B. Z., Andreeff, M., Meli, M., Colombo, G., & Altieri, D. C. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj300 · Cited by 94
Maiti, K. K., Lee, W. S., Takeuchi, T., Watkins, C. L., Fretz, M. M., Kim, D., Futaki, S., Jones, A. T., Kim, K., & Chung, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701346 · Cited by 93
Susceptibility of Cholangiocarcinoma Cells to Parthenolide-Induced Apoptosis
Kim, J., Liu, L., Lee, S. O., Kim, Y., You, K.-R., & Kim, D. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4193 · Cited by 92
Mitochondrial apoptosis without VDAC
Galluzzi, L., & Kroemer, G. (2007) · Nature Cell Biology · doi:10.1038/ncb0507-487 · Cited by 91
Self-citationWhitecross, K. F., Alsop, A. E., Cluse, L. A., Wiegmans, A. P., Banks, K.-M., Coomans, C. P., Peart, M. J., Newbold, A., Lindemann, R. K., & Johnstone, R. W. (2008) · Blood · doi:10.1182/blood-2008-05-156851 · Cited by 90
A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
Pass, H. I., Brewer, G. J., Dick, R., Carbone, M., & Merajver, S. D. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.03.016 · Cited by 90
Zhang, S., Ong, C. N., & Shen, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.03.033 · Cited by 87
Berruti, A., Bitossi, R., Gorzegno, G., Bottini, A., Alquati, P., Matteis, A. D., Nuzzo, F., Giardina, G., Danese, S., Lena, M. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.012 · Cited by 84
Song, J. H., Kandasamy, K., & Kraft, A. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802511200 · Cited by 84
Cited by
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Kwon, J., & Bakhoum, S. F. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0761 · Cited by 1,293
Metadata
- Authors
- Fulda, S., Galluzzi, L., & Kroemer, G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-05-14
- Volume
- 9
- Issue
- 6
- Pages
- 447-464
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2144277227
- Cited by
- 1,629
- References
- 237
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.